Jeff Goater
Partner at The Column Group
Greater Boston
Overview
Work Experience
Board Member
2024 - Current
Board Member
2024
NILO Therapeutics is a biotechnology and therapeutics company.
Raised $9,600,002.00.
Board Member
2024
Kenai Therapeutics focuses on developing therapies for neurodegenerative movement disorders.
Raised $89,000,000.00 from The Column Group, Cure Ventures, Saisei Ventures, Euclidean Capital and Alaska Permanent Fund.
Partner
2024
Venture Partner
2021 - 2023
Board Member
2023
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Raised $211,000,000.00 from Surveyor Capital, The Column Group, Atlas Venture, Alexandria Venture Investments, Casdin Capital, ARCH Venture Partners, Foresite Capital, WTT Investment and Willett Advisors LLC.
Chair
2023
Executive Chair
2022
Board Member
2022
Kallyope uses the science of gut-brain biology to create medicines that transform human health.
Raised $487,200,000.00 from Bill & Melinda Gates Foundation.
Board Member
2021
Interim CEO
2022 - 2023
Atavistik Bio is a biotechnology company that focuses on the discovery and development of novel therapies for metabolic diseases and cancer.
Raised $100,000,000.00 from Lux Capital, Nextech Invest and The Column Group.
Board Member
2021 - 2024
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Raised $259,000,001.00 from Pfizer Venture Investments.